Results

311 - 320 of 364 results for ‘standards’.

  • COVID-19

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/communicable-disease-control-manual/covid-19

    Chapter last reviewed and updated in  October 2024.  Changes were made to the Laboratory testing guidelines. A description of changes can be found at  Updates to the Communicable Disease Control Manual (external link) Epidemiology Expand all Global Epidemiology Global Epidemiology Coronavirus disease 2019 (COVID‑19) is caused by the SARS-CoV-2 virus, which infects the respiratory tract and is transmitted human to human primarily through respiratory droplets and aerosols. Documented transmission has also occurred through direct contact and rarely fomites (objects or materials

  • Acute rheumatic fever

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/acute-rheumatic-fever

    Summary of updates to the guidance Expand all 2025   2025   April  Full chapter update to new format following a significant update to the 2024 Acute Rheumatic Fever Guidelines. Includes changes to the following sections:   Epidemiology – new section At risk and priority populations – new section  The disease – new section   Updated detail on the role of Group A Strep in diagnosis.  Spread of infection – new section   Routine prevention – new section   New overview on primordial, primary and secondary disease prevention.  Case def

  • Waikato

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/hospital-and-specialist-services/mental-health-and-addiction/district-and-regional-services/waikato

    A full list of mental health and addiction services provided by Health New Zealand | Te Whatu Ora Waikato, including contact information, is on Health Information and Services. Mental health and addiction — Health Information and Services (external link) Non-acute adult mental health services Hamilton and Waikato District Council area Adult Mental Health 193 London Street / Private Bag 3200 Hamilton 3240 Phone: 07 834 6902 Fax: 07 834 6900 Email: amhastriage@waikatodhb.health.nz Thames, Coromandel and Hauraki Mental Health and Addictions Service Manaaki Centre / PO Box 707 Thames 3540 Phone:

  • Human Immunodeficiency Virus (HIV)

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/human-immunodeficiency-virus-hiv

    Chapter last reviewed and updated in December 2018. A description of changes can be found at Updates to the Communicable Disease Control Manual . Epidemiology Expand all New Zealand Epidemiology New Zealand Epidemiology Human immunodeficiency virus (HIV) acts by depleting the body’s normal immunological defense mechanism. Acquired immunodeficiency syndrome (AIDS) is the late stage of the spectrum of HIV disease. HIV became notifiable in New Zealand in 2017. Voluntary surveillance was undertaken between 1985 and 2017. AIDS has been a notifiable condition in New Zealand since 1983. HIV infecti

  • Appendix 2: Enteric disease

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/appendix-2-enteric-disease

    ... to return to work is strict adherence to personal hygiene, whether symptomatic or not. The circumstances of each case, carrier or contact should be considered and factors such as their type of employment, availability of toilet and hand washing facilities at work, school or institution and standards of personal hygiene taken into account. For example, a carrier may be relocated temporarily to a role that does not pose an infectious risk.   Pathogen specific exclusion criteria for people at increased risk of transmitting an infection to others Pathogen specific exclusion (restricting ...

  • Clinical Trials Unit

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/health-research/district-and-regional-health-research/wellington-hutt-and-kapiti/clinical-trials-unit

    ... cater for special dietary requirements. Each bed for patients staying overnight has a dedicated television. General information about clinical trials General information about clinical trials Ethics approval is required for all trials, and guidelines exist that set out the established ethical standards that all researchers must meet when undertaking health and disability research in New Zealand. Read more about this on the Health and Disability Ethics Committees website. Health and Disability Ethics Committees (external link) For more clinical trials in New Zealand, visit CenterWatch. New Ze ...

  • 7. Haemophilus influenzae type b (Hib) disease

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/7-haemophilus-inuenzae-type-b-hib-disease

    ... followed by a booster dose in the second year of life should provide sufficient antibody levels to protect against invasive Hib disease to at least the age of 5 years.[ 10 ] 7.4.3. Transport, storage and handling 7.4.3. Transport, storage and handling Transport according to the National Standards for Vaccine Storage and Transportation for Immunisation Providers 2017 (2nd edition) . Store at +2°C to +8°C. Do not freeze. DTaP-IPV-HepB/Hib should be stored in the dark.   DTaP-IPV-HepB/Hib vaccine (Infanrix-hexa) must be reconstituted by adding the entire contents of the pre-filled ...

  • Acquired Immunodeficiency Syndrome (AIDS)

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/acquired-immunodeficiency-syndrome-aids

    Chapter last reviewed and updated in December 2018. A description of changes can be found at Updates to the Communicable Disease Control Manual .   Acquired immunodeficiency syndrome (AIDS) is the late stage of the spectrum of disease caused by the human immunodeficiency virus (HIV). In New Zealand, both AIDS and HIV are notifiable conditions. Epidemiology Expand all New Zealand Epidemiology New Zealand Epidemiology In New Zealand, the number of people developing AIDS declined in the mid-1990s, as it did in many developed countries as a result of improved treatments for people with HIV in

  • Understanding our workforce data

    http://corporat-prod.sites.silverstripe.com/corporate-information/planning-and-performance/health-workforce/health-workforce-plan-2024/understanding-our-workforce-data

    Summary Just as in 2023/24, our workforce data is not high quality. District health boards had different ways of collecting and reporting workforce data. We are still living with these disparate systems and will continue to for some years yet. This means there will be some degree of inaccuracy in our data – but it is the best data we have available and demonstrates the pressures we will face if we do not work differently. Our shortage estimates have assumptions built into them: Most importantly – these estimates are not targets. We will not be able to achieve the growth they identify

  • Pertussis (whooping cough)

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/pertussis

    Note: Macrolide-resistant Bordetella pertussis has been detected by PHF Science and is an emerging issue in Aotearoa New Zealand. The National Public Health Service is currently assessing this and further advice will be incorporated in this chapter when available. No change to antibiotic management is currently advised. Ensure patients and whānau are aware of symptoms and signs of deterioration needing clinical review. Summary of updates to the guidance Expand all 2025 2025 April Full chapter update to new format. Includes changes to the following sections: Global epidemiology – new section